{'fraction_non_alphanumeric': 0.03861410467932741, 'fraction_numerical': 0.027380910590795803, 'mean_word_length': 5.006325110689437, 'pattern_counts': {'":': 0, '<': 3, '<?xml version=': 0, '>': 3, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Recurrent Dissemination of SARS-CoV-2 Through the Uruguayan–Brazilian Border

Uruguay is one of the few countries in the Americas that successfully contained the coronavirus disease 19 (COVID-19) epidemic during the first half of 2020. Nevertheless, the intensive human mobility across the dry border with Brazil is a major challenge for public health authorities. We aimed to investigate the origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains detected in Uruguayan localities bordering Brazil as well as to measure the viral flux across this ∼1,100 km uninterrupted dry frontier. Using complete SARS-CoV-2 genomes from the Uruguayan–Brazilian bordering region and phylogeographic analyses, we inferred the virus dissemination frequency between Brazil and Uruguay and characterized local outbreak dynamics during the first months (May–July) of the pandemic. Phylogenetic analyses revealed multiple introductions of SARS-CoV-2 Brazilian lineages B.1.1.28 and B.1.1.33 into Uruguayan localities at the bordering region. The most probable sources of viral strains introduced to Uruguay were the Southeast Brazilian region and the state of Rio Grande do Sul. Some of the viral strains introduced in Uruguayan border localities between early May and mid-July were able to locally spread and originated the first outbreaks detected outside the metropolitan region. The viral lineages responsible for Uruguayan urban outbreaks were defined by a set of between four and 11 mutations (synonymous and non-synonymous) with respect to the ancestral B.1.1.28 and B.1.1.33 viruses that arose in Brazil, supporting the notion of a rapid genetic differentiation between SARS-CoV-2 subpopulations spreading in South America. Although Uruguayan borders have remained essentially closed to non-Uruguayan citizens, the inevitable flow of people across the dry border with Brazil allowed the repeated entry of the virus into Uruguay and the subsequent emergence of local outbreaks in Uruguayan border localities. Implementation of coordinated bi-national surveillance systems is crucial to achieve an efficient control of the SARS-CoV-2 spread across this kind of highly permeable borderland regions around the world.

Uruguay is one of the few countries in the Americas that successfully contained the coronavirus disease 19 (COVID-19) epidemic during the first half of 2020. Nevertheless, the intensive human mobility across the dry border with Brazil is a major challenge for public health authorities. We aimed to investigate the origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains detected in Uruguayan localities bordering Brazil as well as to measure the viral flux across this ∼1,100 km uninterrupted dry frontier. Using complete SARS-CoV-2 genomes from the Uruguayan-Brazilian bordering region and phylogeographic analyses, we inferred the virus dissemination frequency between Brazil and Uruguay and characterized local outbreak dynamics during the first months (May-July) of the pandemic. Phylogenetic analyses revealed multiple introductions of SARS-CoV-2 Brazilian lineages B.1.1.28 and B.1.1.33 into Uruguayan localities at the bordering region. The most probable sources of viral strains introduced to Uruguay were the Southeast Brazilian region and the state of Rio Grande do Sul. Some of the viral strains introduced in Uruguayan border localities between early May and mid-July were able to locally spread and

INTRODUCTION
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 19 , was first reported in South America on February 26, 2020 and rapidly spread through the region. South America is actually the second-worst affected region in the world, with more than 11 million SARS-CoV-2 cases and nearly 350,000 deaths confirmed as of December, 2020 (Worldometers, 2020). While the virus exponentially spread during the first half of 2020 in most South American countries, the rapid implementation of non-pharmaceutical interventions avoided an exponential growth of SARS-CoV-2 cases in Uruguay Valcarcel et al., 2020). Six months after the first four cases were reported on March 13, 2020, the country registered the lowest total and per capita numbers of SARS-CoV-2 cases (1,808 cases, 520 cases/million inhabitants) and deaths (45 deaths, 13 deaths/million inhabitants) in the region (Worldometers, 2020). Despite Uruguay's success to control the early expansion of SARS-CoV-2, the intensive cross-border human mobility between Uruguay and neighboring countries heavily affected by the pandemic is a major concern for public health authorities, aiming to achieve long-term epidemic control. With an area of approximately 176,000 km 2 and 3.5 million inhabitants, Uruguay borders with Argentina to its west and southwest and with Brazil to its north and east. Of particular concern is the border with Brazil, a porous ∼1,100 km strip of land that separates the southernmost Brazilian state of Rio Grande do Sul (RS) and the Uruguayan departments of Artigas (AR), Rivera (RI), Cerro Largo (CL), Treinta y Tres (TT), and Rocha (RO). The Brazilian-Uruguayan border hosts about 170,000 people that live in twin cities located both sides of a dry border and that maintain an intense economic and social interdependence (Arnson et al., 2020).
With a total area of about 282,000 km 2 and 11.3 million inhabitants, RS is the fifth-most-populous Brazilian state and as of July 31, 2020, registered 66,692 SARS-CoV-2 cases and 1,876 deaths (saude, 2021). After an initial phase of relatively slow growth, the COVID-19 epidemic displayed a sharp increase in RS since early May that coincides with the detection of several outbreaks along Uruguayan border departments. The largest SARS-CoV-2 Uruguayan outbreaks (∼50-100 confirmed cases), outside the metropolitan region during the first months after the first detected cases in the country, were at RI and TT departments in May and June, respectively, while smaller outbreaks (∼10-20 confirmed cases) were detected in AR and CL by July (github, 2020). As of July 31, 2020, a total of 201 SARS-CoV-2 cases were reported in Uruguayan municipalities located along the border with Brazil, which represents 16% of the laboratory-confirmed cases in the country (github, 2020).
Previous phylogenetic analyses revealed the circulation of different predominant SARS-CoV-2 lineages in Brazil (B.1.1.28 and B.1.1.33) (Candido et al., 2020;Resende et al., 2020b) and Uruguay (A.5 and B.1) (Elizondo et al., 2020;Salazar et al., 2020), thus supporting independent viral seeding events and little viral exchanges between these neighboring countries during the very early phase of the epidemic. However, most Uruguayan SARS-CoV-2 samples previously analyzed were from Montevideo, the capital city of the country, and there is only scarce information concerning the virus strains circulating in Uruguayan localities bordering Brazil.
We generated 122 SARS-CoV-2 whole-genome sequences recovered from cases isolated at Uruguayan border departments (n = 54) as well as in the southernmost Brazilian state of RS (n = 68) to gain insight into the origin and dynamics of SARS-CoV-2 spread at the Brazilian-Uruguayan border. Our study provides important findings that demonstrate the relevance of building bi-national genomic surveillance workforces in countries with porous and dynamic bordering regions.

SARS-CoV-2 Samples and Ethical Aspects
A total of 122 SARS-CoV-2 whole-genomes were recovered from nasopharyngeal-throat combined swab samples collected from deceased cases (n = 5), clinically ill or asymptomatic individuals that reside in five different Uruguayan departments (n = 54) at the Brazilian border and 41 different municipalities of the RS Brazilian state (n = 68) (Figure 1 and Supplementary

SARS-CoV-2 Whole-Genome Consensus Sequences
Whole-genome consensus sequences obtained from ONT were generated using an adaptation of the nCoV-2019 novel coronavirus ARTIC bioinformatics protocol 1 as in Resende et al. (2020c) with adjustments that are available at https: //github.com/iferres/ncov2019-artic-nf. For Illumina and Ion Torrent, BCFtools was used for single-nucleotide polymorphism (SNP) calling (mpileup), SNP filtering, and consensus sequences reconstruction (consensus function) as described in detail in the Supplementary Material Section 1. Positions of interest were manually inspected to resolve undetermined bases. All genomes obtained in this study were uploaded at the EpiCoV database in the GISAID initiative under the accession numbers EPI_ISL_729794 to EPI_ISL_729861 (Brazilian genomes), and accession numbers of Uruguayan genomes are in Supplementary

SARS-CoV-2 Genotyping and Maximum Likelihood Phylogenetic Analyses
Uruguayan and Brazilian SARS-CoV-2 genome sequences were initially assigned to viral lineages according to Rambaut et al. (2020), using the pangolin web application 2 and later confirmed using maximum likelihood (ML) phylogenetic analyses. ML phylogenetic analyses were performed with the PhyML 3.0 program (Guindon et al., 2010), using an online web server (Guindon et al., 2005; Supplementary Material Section 1). Branch support was assessed by the approximate likelihood-ratio test based on a Shimodaira-Hasegawa-like procedure (SH-aLRT) with 1,000 replicates (Anisimova and Gascuel, 2006).

Phylogeographic Analyses
The previously generated ML trees were employed for the ancestral character state reconstruction (ACR) of epidemic locations with PastML (Ishikawa et al., 2019), using the marginal posterior probabilities approximation (MPPA) method with an F81-like model. We next constructed a time-scaled Bayesian phylogenetic tree for the Brazilian and Uruguayan sequences belonging to the B.1.1.28 and B.1.1.33 lineages using the Bayesian Markov chain Monte Carlo (MCMC) approach implemented in BEAST 1.10 (Suchard et al., 2018) with BEAGLE library v3 to improve computational time (Supplementary Material Section 1). Viral migrations were reconstructed using a reversible discrete phylogeographic model with a continuous-time Markov chain (CTMC) rate reference prior (Ferreira and Suchard, 2008).

Within-Host Diversity
Only those synapomorphic sites with at least 100 reads were kept for further analysis. As samples were obtained by three different sequencing technologies with different error profiles, a Shannon entropy value (H) was estimated per observation based on the four allele frequencies. We determined a linear model to estimate the contributions of sequencing technology, sample, and synapomorphic site to the observed A, C, G, and T frequencies (summarized as H): H exp 1/4 ∼ SEQ + SAMPLE + MUTATION. We used H exp 1/4 to better fit a normal distribution (Supplementary Figure 1C

Prevalent SARS-CoV-2 Lineages at the Uruguayan-Brazilian Border
To understand the dynamics of SARS-CoV-2 spread at the Brazilian-Uruguayan border, we sequenced the viral genome from 54 individuals diagnosed between May 5 and July 27 in the five Uruguayan border departments (AR, CL, RI, RO, and TT) and from 68 individuals diagnosed at 42 different municipalities from RS state collected between March 9 and August 16, 2020 ( Figure 1A and Supplementary Table 1 in Supplementary Material Section 2). These sequences were combined with a few SARS-CoV-2 whole-genome sequences from Uruguayan individuals diagnosed at RI (n = 5) and Montevideo (n = 1) and from Brazilian individuals sampled in RS (n = 13) retrieved from the EpiCoV database in the GISAID initiative. The resulting final dataset of 59 SARS-CoV-2 sequences from Uruguayan departments bordering Brazil represents 30% of all laboratory-confirmed cases (n = 201) in that region between March and July 2020. A low fraction of Uruguayan (∼4%) and no Brazilian individuals here sequenced reported international travel or contact with traveling people, indicating that most of them were locally infected. The SARS-CoV-2 genotyping of Uruguayans and Brazilians diagnosed at the border region revealed a quite homogenous pattern as all sequences belonged to the B.1 lineage characterized by the D614G mutation at the spike protein. Furthermore, all SARS-CoV-2 sequences from Uruguayan departments at the border region belonged to the dominant Brazilian lineages B.1.1.33 (85%) and B.1.1.28 (15%) ( Figure 1B). Although different B.1 sub-clades were identified in RS, the Brazilian lineages B.1.1.33 (58%) and B.1.1.28 (21%) were also the most prevalent across all state regions ( Figure 1B).

Identification of Major SARS-CoV-2 Uruguayan-Brazilian Clades
Phylogenetic trees of SARS-CoV-2 lineages B.1.1.28 and B.1.1.33 were inferred to explore the Uruguayan and Brazilian RS sequence clustering with sequences from other Brazilian states and worldwide. The ML phylogenetic analyses revealed that most SARS-CoV-2 sequences from Uruguay branched within four highly supported (aLRT = 1) Uruguayan clades (Figure 2). The largest B.1.1.33 Uruguayan clade TT-I 33 (n = 28) comprises all sequences detected in TT between June 18 and July 2. The B.1.1.33 clades RI-I 33 (n = 19) and RI-II 33 (n = 3) comprise all sequences detected in RI between May 5 and June 5 and in late July, respectively (Figure 2A). The B.1.1.28 Uruguayan clade AR-I 28 (n = 4) comprises all sequences detected in AR (Bella Unión City) in late July ( Figure 2B). The B.1.1.33 sequence detected in March in Montevideo as well as the B.1.1.28 sequences detected in July in AR (Artigas City), CL, RO, and RI appeared as dyads or singletons.
The four major Uruguayan clades were nested among basal sequences from Brazil, forming three highly supported (aLRT = 1) Brazilian-Uruguayan clades (Figure 2). The largest clade (n = 39) designated as BR-UY-I 33 comprises the Uruguayan clade TT-I 33 , a group of basal Brazilian sequences (n = 10) isolated in São Paulo and Rio de Janeiro states between March 24 and June 6 and one sequence from Ireland. The second Brazilian-Uruguayan clade designated as BR-UY-II 33 comprises the Uruguayan clades RI-I 33 (n = 19) and RI-II 33 (n = 3) and a group of Brazilian sequences (n = 8) isolated in different municipalities from RS between May 6 and July 28 (Figure 2A). The third Brazilian-Uruguayan clade designated as BR-UY-I 28 comprises the Uruguayan clade AR-I 28 and one Brazilian sequence isolated in the São Paulo state on March 20 ( Figure 2B). Our analysis also identified one highly supported (aLRT = 1) monophyletic group designated as BR-RS-I 33 (n = 12) that only comprises sequences from RS (Figure 2A).

Spatiotemporal Dissemination of SARS-CoV-2 Uruguayan-Brazilian Clades
To identify the number of independent introduction events of SARS-CoV-2 into Uruguay and their most probable  To more accurately infer the geographic source and timing of virus introductions in Uruguay, we conducted Bayesian-based phylogeographic and molecular clock analyses of Brazilian and Uruguayan sequences. Viral migrations were inferred using a discrete diffusion model between 13 locations: four Brazilian regions (Southeast, Northeast, North, and Central-West), three southern Brazilian states (RS, Paraná, and Santa Catarina), and six Uruguayan locations (AR, CL, MO, TT, RI, and RO). Bayesian analyses recovered the same Uruguayan and Brazilian clades previously detected by the ML analyses, with two exceptions: the clade RI-II 33 branched outside the clade BR-UY-II 33 and no Brazilian sequences branched with high support with clade AR-II 28 . Bayesian analyses pointed that the Brazilian southeast region was the most probable source [posterior state probability (PSP) ≥ 0.96] of all B.1.1.28 and B.1.1.33 viruses introduced in Uruguay, with the exception of clade RI-I33, a B.1.1.28 sequence from RI that most probably originated in Brazil-RS (PSP ≥ 0.85), and the B.1.1.33 strain from Montevideo that probably originated in the North Brazilian region (PSP = 1) (Figure 4 and Supplementary Figures 3, 4).

SARS-CoV-2 Lineage-Defining SNPs and Intra-Patient Viral Diversity
Severe acute respiratory syndrome coronavirus 2 Brazilian-Uruguayan clades here identified displayed several lineagedefining SNPs (single nucleotide polymorphisms/mutations) that were sequentially fixed during evolution and dissemination of each lineage (Figure 4 and Supplementary Table 3 in Supplementary Material Section 2). The Uruguayan/Brazilian lineages (BR-UY-I 33 , BR-UY-II 33 , and BR-UY-I 28 ) and the Brazilian lineage BR-RS-I 33 were all defined by one SNP. One SNP also characterized all sequences from clade TT-I 33 plus some basal Brazilian strains from São Paulo, two SNPs defined clade TT-I 33 , and one additional SNP characterized all except one basal sequence of clade TT-I 33 . Two SNPs characterized all sequences from clade RI-I 33 plus some basal Brazilian strains from RS, one SNP defined clade RI-I 33 , and three SNPs defined clade RI-II 33 . The clade AR-I 28 was defined by 10 SNPs (Supplementary Table 3 in Supplementary  Material Section 2).
To understand the dynamics of lineage-defining SNPs, we examined within-host diversity patterns by analyzing the mapped reads at every SNP genomic position in samples from the two major B.

Supplementary Material Section 2).
Our analysis of SNP positions reveals a clear-cut allocation of mutant alleles, which displayed either very low (<10%) or high (>80%) frequency within each clade (Figures 5A,B). Importantly, no sequences appeared in the 10-65% frequency range (Figures 5A,B). The most notable example was the mutation ORF1ab:15108C > T fixed during the dissemination of clade TT-I 33 that appeared at a very low frequency (<5%) in the basal Uruguayan sample M70 ( Figure 5A). Indeed, the estimated frequency of the mutant allele in basal sequences from a given clade was not higher than the corresponding frequency detected in sequences from a different clade ( Figure 5C). While allele frequencies were calculated from three different technologies (Illumina, Ion Torrent, and ONT) and this could introduce some bias ( Supplementary  Figures 1, 2 in Supplementary Material Section 3), for most samples only ONT data were available. It has been shown that in our conditions (we only kept for analyses those synapomorphic sites with at least 100× read coverage), ONT sequencing enables detection of within-specimen single-nucleotide variants at frequencies equal to and higher than ∼40% with adequate accuracy (Bull et al., 2020). Besides, considering intermediate allele frequencies as those in 40-60% range (Bull et al., 2020), small differences in accuracy and precision would not change our main finding regarding the absence of sequence with intermediate frequencies in this dataset.

DISCUSSION
Public health measures implemented by authorities were able to contain the early local expansion of SARS-CoV-2 in Uruguay, but the intensive human mobility across the contiguous dry borderland with Brazil can compromise long-term control of the epidemic. Indeed, our analyses showed that the COVID-19 epidemic in the Uruguayan-Brazilian border is mostly dominated by the Brazilian lineages B.1.1.33 and B.1.1.28 and that independent introductions of these lineages seeded the early outbreaks of SARS-CoV-2 detected in Uruguayan departments at the bordering region.
Our phylogeographic analyses support that both SARS-CoV-2 lineages most probably arose in the Southeast Brazilian region (PSP = 1) during February 2020, consistent with previous findings (Candido et al., 2020;Resende et al., 2020c), and were later disseminated at multiple times into the Southern region, making up 79% of all viral strains from the RS state. We distinguished two B.1.1.33 local sub-clades that together comprise 45% of all B.1.1.33 strains from RS: the clade BR-RS-I 33 that arose by the end of March seems to have remained restricted to this Brazilian state, and the clade BR-UY-II 33 that arose between late March and early April was later disseminated to Uruguay. These findings indicate that the COVID-19 epidemic in the Southern Brazilian state of RS was mostly seeded by epidemics from the Southeastern region.
The molecular epidemiologic profile of the COVID-19 epidemic at Uruguayan border localities (dominated by lineages B.1.1.33 and B.1.1.28) coincides with the observed pattern in RS state and differs from the profile of early outbreaks in the capital city of Montevideo (dominated by lineages A.5 and B.1) (Elizondo et al., 2020;Salazar et al., 2020). Our phylogeographic analyses support that the Southeast Brazilian region and RS were the most probable sources of six and two viral introductions, respectively, into Uruguay. This finding, however, should be interpreted with caution because a potential sampling bias across Brazilian regions might influence phylogeographic reconstructions and the actual number of viral introductions from RS into Uruguay might be higher than here estimated .
Our study supports that some of the viral strains introduced in the Uruguayan cities of Rivera, Treinta y Tres, and Bella Unión between early May and mid-July were able to spread locally. The most successfully disseminated local lineages were RI-I 33 and TT-I 33 that drove the major early outbreaks detected in Rivera and Treinta y Tres in May and June, respectively. Our analysis supports that SARS-CoV-2 Uruguayan clades displayed a variable period of local cryptic transmission, lasting between 1 and 3 weeks. Furthermore, the major Uruguayan clades took between 10 days and nearly a month to be controlled. Long periods of cryptic circulation and/or long times to control represent a potential risk of viral dissemination from Uruguayan border localities into the metropolitan region.
Our phylogenetic analyses identified several sub-clusters inside the B.1.1.28 and B.1.1.33 lineages defined by a set of synonymous and non-synonymous mutations with respect to the ancestral viruses that arose in Brazil in February 2020. The number of defining mutations ranges from one to 11 SNPs and correlates with the lineage T MRCA , as lineages with the youngest T MRCA displayed more SNPs than those with older ones. This is consistent with a molecular clock model (Duchene et al., 2020) and with the notion that most SNPs are probably evolutionarily neutral (van Dorp et al., 2020). Thus, while our study emphasizes the rapid genetic differentiation of regional SARS-CoV-2 lineages in South America and the relevance of molecular epidemiologic studies to track their emergence and spread, the observed SNPs should not be interpreted as an adaptive signature of higher viral transmissibility (MacLean et al., 2020).
Previous studies support that intra-host SARS-CoV-2 genetic diversity is transmissible, and information about within-host diversity could provide further resolution for identification of geographic transmission clusters (Lythgoe et al., 2020) and to trace how low-frequency mutations become fixed in local clusters (Popa et al., 2020). Our analyses of intrahost diversity, however, revealed that mutations present at low frequency (<10%) in basal strains of major Uruguayan-Brazilian clusters become highly prevalent (>80%) during subsequent transmissions, without evidence of basal samples with intermediate-frequency alternative alleles. These findings support that minor intra-host SARS-CoV-2 variants could become rapidly fixed due to stochastic events during inter-host transmissions and later perpetuated along transmission chains (Böhmer et al., 2020).
In summary, our study demonstrates for the first time a recurrent viral flux across the Uruguayan-Brazilian border, with multiple introductions of the SARS-CoV-2 Brazilian lineages B.1.1.28 and B.1.1.33 into Uruguayan localities at the border region and the potential of those viral introductions to ignite local outbreaks in Uruguay. These findings provide clear evidence that public health measures for viral control were not able to fully suppress the dissemination of SARS-CoV-2 along the Uruguayan-Brazilian border, and this possesses a major challenge for long-term epidemic control in Uruguay. The present work also highlights the relevance of bi-national consortiums for genomic surveillance of SARS-CoV-2 to obtain in-depth insights and better control of viral spread across highly permissive international borders.

DATA AVAILABILITY STATEMENT
Genome sequences were submitted to the EpiCoV/GISAID database, and accession numbers are specified in Supplementary Tables 1, 2 and in Supplementary Section 2.

ETHICS STATEMENT
The studies involving human participants were reviewed and approved by the SASA Ethics Committee: CEI-SASA FIOCRUZ-IOC Ethics Committee: 68118417.6.0000.5248, and Brazilian Ministry of Health SISGEN: A1767C3. The patients/participants provided their written informed consent to participate in this study.

AUTHOR CONTRIBUTIONS
LS made significant contributions in the post-processing of raw sequencing data, study design, coordination of Uruguayan group, funding acquisition, verifying underlying data, and writing the original draft. DM was in charge of phylogenetic and phylogeographic analyses, verified underlying data, and wrote original draft. NRg made significant contribution in the post-processing of raw sequencing data, verifying underlying data, variant analysis, and writing the original draft. TF-C was in charge of sequencing in Uruguay and read and corrected the manuscript. VN is the head of a diagnostic center in the Sanatorio Americano, obtained funding, and reviewed and edited the manuscript. MA, TP, and NRy worked on the diagnosis in Sanatorio Americano and read the manuscript. GB made significant contributions in the study design, coordination between Uruguayan and Brazilian institutions, coordination of phylogeographic and phylogenetic analyses, verification of underlying data, and writing the original draft. RC made significant contributions in the coordination of diagnostic centers in the Uruguayan non-metropolitan area, study design, and editing and review of the manuscript. FT worked on the diagnosis in CENUR-Norte, Uruguay, worked on nanopore sequencing in Uruguay centers, and edited and reviewed the manuscript. MB worked on nanopore sequencing in Uruguay centers and read the manuscript. MG made significant contributions in the technical support at the Institut Pasteur de Montevideo, helped in writing the grant for funding, and carefully edited and reviewed the manuscript. CSa made significant contributions in the bioinformatic analysis of sequencing data from Uruguayan centers and reviewed the manuscript. MV, AL, MC, LMay, and MSa worked on diagnosis in CENUR-Norte, Uruguay, and reviewed the manuscript. YV worked on diagnosis in Laboratorio DILAVE/MGAP-INIA-UdelaR-Tacuarembó, Uruguay, and reviewed the manuscript. CA worked on diagnosis in CURE-Rocha, Uruguay, and reviewed the manuscript. CSe worked on nanopore sequencing at Institut Pasteur de Montevideo, Uruguay, and reviewed the manuscript. IF made significant contributions in the software and reviewed the manuscript. PS and JS worked on Ion Torrent sequencing at Instituto de Investigaciones Biológicas Clemente Estable, Uruguay, and reviewed the manuscript. RF and CM made significant contributions in sequencing design, library preparation, and sequencing (Ion Torrent). MB-G worked on logistic support and reviewed the manuscript. IA worked on phylogenetic and phylogeographic analyses and reviewed the manuscript. PR coordinated the Brazilian SARS-CoV-2 sequencing team using Nanopore, Illumina, and Ion Torrent platforms at the National Reference Laboratory Fiocruz; analyzed the raw sequencing data; and revised and edited the manuscript. TG and MM performed the extraction and the SARS-CoV-2 detection by real-time RT-PCR locally in the Rio Grande do Sul state and revised the manuscript. LMar is responsible for the epidemiological team in the Rio Grande do Sul state, collected all the epidemiological data from Brazilian samples included in this study, and revised the manuscript. FM is responsible for extraction and the SARS-CoV-2 confirmation by real-time RT-PCR at the National Reference Laboratory Fiocruz and revised the manuscript. LA and AM are responsible for whole-genome SARS-CoV-2 amplification, library construction, sequencing, and revision of the manuscript. MMS made significant contribution in financial support acquisition and revision and editing of the manuscript. All authors contributed to the article and approved the submitted version.